rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2003-2-25
|
pubmed:abstractText |
The authors compared the functional activation state and cytokine secretion profile of CD8+ T cells in patients with relapsing-remitting and secondary progressive (SP) MS to those in normal controls. In addition, they examined cytokine secretion in relationship to single nucleotide polymorphism (SNP) analysis of cytokine genes. A significant increase in lymphotoxin secretion from anti-CD3-stimulated CD8+ T cells was observed in patients with SPMS as compared to normal controls. The authors found no significant differences in SNP frequency or in secretion of other cytokines.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1526-632X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
25
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
702-5
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12601116-Adult,
pubmed-meshheading:12601116-Antibodies,
pubmed-meshheading:12601116-Antigens, CD3,
pubmed-meshheading:12601116-CD8-Positive T-Lymphocytes,
pubmed-meshheading:12601116-Cell Division,
pubmed-meshheading:12601116-Cell Separation,
pubmed-meshheading:12601116-Cells, Cultured,
pubmed-meshheading:12601116-Cytokines,
pubmed-meshheading:12601116-Female,
pubmed-meshheading:12601116-Flow Cytometry,
pubmed-meshheading:12601116-Gene Frequency,
pubmed-meshheading:12601116-Humans,
pubmed-meshheading:12601116-Lymphotoxin-alpha,
pubmed-meshheading:12601116-Male,
pubmed-meshheading:12601116-Middle Aged,
pubmed-meshheading:12601116-Multiple Sclerosis, Chronic Progressive,
pubmed-meshheading:12601116-Multiple Sclerosis, Relapsing-Remitting,
pubmed-meshheading:12601116-Polymorphism, Single Nucleotide,
pubmed-meshheading:12601116-Reference Values
|
pubmed:year |
2003
|
pubmed:articleTitle |
Activated CD8+ T cells in secondary progressive MS secrete lymphotoxin.
|
pubmed:affiliation |
Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Controlled Clinical Trial
|